Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Bourge

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Circulation|September 17, 2008
Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressuresMichael R Zile, Tom D Bennett, Martin St John Sutton, et al.
Journal of the American College of Cardiology|March 18, 2008
Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF studyRobert C Bourge, William T Abraham, Philip B Adamson, et al.
Pulmonary Circulation|November 15, 2019
Long-term results of the DelIVery for Pulmonary Arterial Hypertension trialMardi Gomberg-Maitland, Robert C Bourge, Shelley M Shapiro, et al.
Chest|July 12, 2016
Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH TrialRobert C Bourge, Aaron B Waxman, Mardi Gomberg-Maitland, et al.
American Heart Journal|August 9, 2005
Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS)John R Teerlink, John J V McMurray, Robert C Bourge, et al.
The American Journal of Medicine|November 22, 2013
Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failureAli Ahmed, Robert C Bourge, Gregg C Fonarow, et al.
Congestive Heart Failure (Greenwich, Conn.)|September 13, 2011
Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of The Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (REDUCEhf) trialPhilip B Adamson, Michael R Gold, Tom Bennett, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 22, 2005
Multi-organ transplantation: is there a protective effect against acute and chronic rejection?Laura J Pinderski, James K Kirklin, David McGiffin, et al.
Lancet (London, England)|January 22, 2008
Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trialGuillermo Torre-Amione, Stefan D Anker, Robert C Bourge, et al.
JAMA|November 8, 2007
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trialsJohn J V McMurray, John R Teerlink, Gadi Cotter, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Circulation|September 17, 2008
Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressuresMichael R Zile, Tom D Bennett, Martin St John Sutton, et al.
Journal of the American College of Cardiology|March 18, 2008
Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF studyRobert C Bourge, William T Abraham, Philip B Adamson, et al.
Pulmonary Circulation|November 15, 2019
Long-term results of the DelIVery for Pulmonary Arterial Hypertension trialMardi Gomberg-Maitland, Robert C Bourge, Shelley M Shapiro, et al.
Chest|July 12, 2016
Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH TrialRobert C Bourge, Aaron B Waxman, Mardi Gomberg-Maitland, et al.
American Heart Journal|August 9, 2005
Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS)John R Teerlink, John J V McMurray, Robert C Bourge, et al.
The American Journal of Medicine|November 22, 2013
Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failureAli Ahmed, Robert C Bourge, Gregg C Fonarow, et al.
Congestive Heart Failure (Greenwich, Conn.)|September 13, 2011
Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of The Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (REDUCEhf) trialPhilip B Adamson, Michael R Gold, Tom Bennett, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 22, 2005
Multi-organ transplantation: is there a protective effect against acute and chronic rejection?Laura J Pinderski, James K Kirklin, David McGiffin, et al.
Lancet (London, England)|January 22, 2008
Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trialGuillermo Torre-Amione, Stefan D Anker, Robert C Bourge, et al.
JAMA|November 8, 2007
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trialsJohn J V McMurray, John R Teerlink, Gadi Cotter, et al.
Pageof 10